Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In the past years, it has been shown that kynurenines pathway is a regulator of both the innate and the adaptive immune responses. Particularly, the initial enzyme of this pathway, indoleamine 2,3-dioxygenase (IDO), is implicated in maintaining tolerance during pregnancy, and also can be expressed in tumors to avoid the immune attack. In this chapter, we will describe how the kynurenine pathway affects the immune system with important implications both in physiology and in pathology. The incorrect activation or blockade suppressive properties of the kynurenine pathway are also implicated in a number of other diseases such as AIDS or autoimmune diseases.

Original publication

DOI

10.1016/s0065-2423(07)00007-8

Type

Chapter

Publication Date

01/2008

Volume

45

Pages

155 - 197

Addresses

Laboratory of Biochemistry, University Clinic of Navarra, Avda Pio XII 36, Pamplona 31008, Spain.

Keywords

Humans, Fetal Death, Kynurenine, Immune Tolerance, Pregnancy, Female, Indoleamine-Pyrrole 2,3,-Dioxygenase